LEADER 00000cam a22002893a 4500
001 16210981
003 SE-LIBR
003 LT
007 cr||||||||||||
008 140315s2014 xx |||| o |||| ||eng d
020 9781908986689
041 eng
072 7 VFD|2bicssc
100 1 Biller, José
245 10 Evidence-based Management of Stroke|h[Elektronisk resurs]
264 |bTFM Publishing Ltd,|c2014
520 Winner of a HIGHLY COMMENDED AWARD in the Neurology
category of the 2012 BMA Medical Book Competition. More
than five million people die from stroke each year. Stroke
is also the leading cause of adult disability, affecting
over 20 million people worldwide, with two-thirds of
stroke victims left permanently disabled. We now know that
speed of intervention is critical and patient outcomes are
determined by a very narrow therapeutic window, during
which physicians need to be able to make their choice of
treatment rapidly, based on the best evidence available.
The purpose of this book is to review that evidence, for
both medical and surgical therapies as well as
preventative strategies, drawing on the expertise of
leading international authorities to distinguish the
issues for which there is a consensus on best practice
from those for which the evidence remains inconclusive.
For example, for patients with acute ischemic stroke the
first choice is intravenous thrombolytic therapy, but does
a treatment window of 0-3 hours deliver outcomes
significantly better than one of 3-4.5 hours? Arterial
hypertension is the single most important modifiable risk
factor for ischemic stroke, but what are the effects of
blood pressure reduction among acute stroke patients? How
effective is blood pressure lowering in primary
intracerebral hemorrhage? What are the arguments in favour
of continuation versus temporary discontinuation of
antihypertensive therapy immediately after acute ischemic
stroke? Endovascular procedures (carotid angioplasty/
stenting) are increasingly important but what do the data
tell us about their safety? Or durability? How do they
compare with carotid endarterectomy? The management of
unruptured intracranial aneurysms is rife with
controversies; clip, coil, wait and watch? The authors
examine the evidence for and against. Other sections
examine the impact of various risk factors, and special
populations. A section on stroke after cardiovascular
surgeries reviews the incidence and management of stroke
following a whole range of procedures. Another examines
special risks during pregnancy. Lastly, the book reviews
our understanding of childhood stroke and presents current
best practice recommendations for this most challenging
group of patients. [Elib]
520 Winner of a HIGHLY COMMENDED AWARD in the Neurology
category of the 2012 BMA Medical Book Competition. More
than five million people die from stroke each year. Stroke
is also the leading cause of adult disability, affecting
over 20 million people worldwide, with two-thirds of
stroke victims left permanently disabled. We now know that
speed of intervention is critical and patient outcomes are
determined by a very narrow therapeutic window, during
which physicians need to be able to make their choice of
treatment rapidly, based on the best evidence available.
The purpose of this book is to review that evidence, for
both medical and surgical therapies as well as
preventative strategies, drawing on the expertise of
leading international authorities to distinguish the
issues for which there is a consensus on best practice
from those for which the evidence remains inconclusive.
For example, for patients with acute ischemic stroke the
first choice is intravenous thrombolytic therapy, but does
a treatment window of 0-3 hours deliver outcomes
significantly better than one of 3-4.5 hours? Arterial
hypertension is the single most important modifiable risk
factor for ischemic stroke, but what are the effects of
blood pressure reduction among acute stroke patients? How
effective is blood pressure lowering in primary
intracerebral hemorrhage? What are the arguments in favour
of continuation versus temporary discontinuation of
antihypertensive therapy immediately after acute ischemic
stroke? Endovascular procedures (carotid angioplasty/
stenting) are increasingly important but what do the data
tell us about their safety? Or durability? How do they
compare with carotid endarterectomy? The management of
unruptured intracranial aneurysms is rife with
controversies; clip, coil, wait and watch? The authors
examine the evidence for and against. Other sections
examine the impact of various risk factors, and special
populations. A section on stroke after cardiovascular
surgeries reviews the incidence and management of stroke
following a whole range of procedures. Another examines
special risks during pregnancy. Lastly, the book reviews
our understanding of childhood stroke and presents current
best practice recommendations for this most challenging
group of patients. [Elib]
520 Winner of a HIGHLY COMMENDED AWARD in the Neurology
category of the 2012 BMA Medical Book Competition. More
than five million people die from stroke each year. Stroke
is also the leading cause of adult disability, affecting
over 20 million people worldwide, with two-thirds of
stroke victims left permanently disabled. We now know that
speed of intervention is critical and patient outcomes are
determined by a very narrow therapeutic window, during
which physicians need to be able to make their choice of
treatment rapidly, based on the best evidence available.
The purpose of this book is to review that evidence, for
both medical and surgical therapies as well as
preventative strategies, drawing on the expertise of
leading international authorities to distinguish the
issues for which there is a consensus on best practice
from those for which the evidence remains inconclusive.
For example, for patients with acute ischemic stroke the
first choice is intravenous thrombolytic therapy, but does
a treatment window of 0-3 hours deliver outcomes
significantly better than one of 3-4.5 hours? Arterial
hypertension is the single most important modifiable risk
factor for ischemic stroke, but what are the effects of
blood pressure reduction among acute stroke patients? How
effective is blood pressure lowering in primary
intracerebral hemorrhage? What are the arguments in favour
of continuation versus temporary discontinuation of
antihypertensive therapy immediately after acute ischemic
stroke? Endovascular procedures (carotid angioplasty/
stenting) are increasingly important but what do the data
tell us about their safety? Or durability? How do they
compare with carotid endarterectomy? The management of
unruptured intracranial aneurysms is rife with
controversies; clip, coil, wait and watch? The authors
examine the evidence for and against. Other sections
examine the impact of various risk factors, and special
populations. A section on stroke after cardiovascular
surgeries reviews the incidence and management of stroke
following a whole range of procedures. Another examines
special risks during pregnancy. Lastly, the book reviews
our understanding of childhood stroke and presents current
best practice recommendations for this most challenging
group of patients. [Elib]
653 E-bok
653 eLib
655 4 E-böcker
700 1 Ferro, José M|4aut
852 |5Mo|bMo|cE-Bok|xorigin:Elib|zOnline EPUB med Adobe-
kryptering (3.43 MB)
856 4 |uhttps://malmo.elib.se/Books/Details/1018606|zLåna som E-
bok
